DSM Invests in Probiotics Startup

12:04 PM MST | November 9, 2007 | Chemical Week Editorial Staff

DSM says that its DSM Ventures subsidiary and private equity firm Capital Resource Partners (CRP; Boston) have each invested in Ganeden Biotech (Mayfield Heights, OH), a manufacturer of dietary supplements focused on digestive health. DSM and CRP have invested a combined $12 million. Further financial details were not disclosed. Ganeden’s products are based on the use of a spore-forming and lactic acid-producing bacterium, Bacillus...